OMNI SURGICAL SYSTEM
Report
- Report Number
- 3010363671-2019-00002
- Event Type
- Injury
- Date Received
- December 13, 2019
- Date of Event
- October 17, 2019
- Report Date
- December 13, 2019
- Manufacturer
- SIGHT SCIENCES, INC.
- Product Code
- MRH
- UDI-DI
- 00858027006310
- PMA / PMN Number
- K173332
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- PHYSICIAN
Narratives
ALL PERTINENT INFORMATION AVAILABLE TO SIGHT SCIENCES, INC. HAS BEEN SUBMITTED. THE COMPANY IS SUBMITTING THIS MDR TO ENSURE FULL COMPLIANCE WITH 21 CFR PART 803. MFR REFERENCE #: (B)(4).
ON (B)(6) 2019, THE SURGEON PERFORMED VISCODILATION AND GONIOTOMY WITH THE OMNI SURGICAL SYSTEM AS WELL AS CATARACT SURGERY. SURGERY WAS UNEVENTFUL AND THERE WERE NO INTRAOPERATIVE COMPLICATIONS. AT ONE WEEK POST-SURGERY, THE PATIENT HAD HYPOTONY WITHOUT ANY CLINICAL SIGNS AND THE VISUAL ACUITY WAS UNCHANGED FROM PRE-OP (20/50). THE PATIENT WAS PRESCRIBED STEROIDS TO INCREASE THE IOP. THE PATIENT'S PRESSURE CONTINUED TO BE LOW FOR THE FIRST MONTH POST-SURGERY. AT APPROXIMATELY 6 WEEKS POST-SURGERY ((B)(6) 2019), THE IOP INCREASED TO 10 MMHG BUT THE VISUAL ACUITY HAD DECREASED TO 20/400. AT APPROXIMATELY 2 MONTHS POST-SURGERY ((B)(6) 2019), WITH THE PRESSURE STILL LOW AND THE VISION AT 20/200, THE PATIENT WAS SEEN BY A NEURO-OPHTHALMOLOGIST WHO DIAGNOSED THE PATIENT WITH PAPILLEDEMA DUE TO AN EXTENDED PERIOD OF LOW PERFUSION AS A RESULT OF LOW IOP. THE PATIENT IS UNDER TREATMENT AND OBSERVATION. THE OPTIC NERVE SWELLING HAS REDUCED BUT THE VISION IS STILL 20/200. THE DOCTOR IS UNABLE TO DETERMINE THE PATHOPHYSIOLOGY BEHIND THE PAPILLEDEMA.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1259100 | OMNI SURGICAL SYSTEM | VISCOELASTIC INJECTOR | MRH | SIGHT SCIENCES, INC. | 05600 | 00858027006310 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Other |